Sun Pharma Advanced Research Co (SPARC) Shareholding Pattern
NSE: SPARC • Promoter, FII, DII Holdings for Tickjournal
Promoter Holding65.67%
FII Holding2.04%
DII Holding0.78%
Public Holding19.20%
Total Shareholders144,810
As ofDec 2025
View the latest shareholding pattern of Sun Pharma Advanced Research Co (SPARC) including promoter, FII, DII, and public holdings.
Track SPARC ownership changes over time and document your investment thesis in Tickjournal — your personal trade journal.
(See SPARC fair value)
Sun Pharma Advanced Research Co (SPARC) Shareholding Summary
Promoter holding remains unchanged at 65.67% in Dec 2025
FII/FPI have increased holdings from 1.76% to 2.04% in Dec 2025
DIIs have decreased holdings from 1.05% to 0.78% in Dec 2025
Institutional investors have increased holdings from 2.81% to 2.82% in Dec 2025
Public holding has increased from 18.94% to 19.20% in Dec 2025
Number of shareholders increased from 136,997 to 144,810 in Dec 2025
SPARC Quarterly Ownership Changes
Quarter-over-quarter changes for Sun Pharma Advanced Research Co from Sept 2025 to Dec 2025.
Promoter Holding Change
Sept 2025 to Dec 2025
No Change
FII Holding Change
Sept 2025 to Dec 2025
+0.28%
DII Holding Change
Sept 2025 to Dec 2025
-0.27%
Public Holding Change
Sept 2025 to Dec 2025
+0.26%
Sun Pharma Advanced Research Co (SPARC) Quarterly Shareholding Trends
Understanding Sun Pharma Advanced Research Co (SPARC) Shareholding Pattern
Sun Pharma Advanced Research Co shareholding pattern reveals who owns SPARC stock and how ownership changes over time. High promoter stakes in SPARC often signal management confidence, while rising FII/DII holdings suggest growing institutional interest. Use Tickjournal to log these insights alongside your SPARC trades. Sun Pharma Advanced Research C yearly highs lows
Combine SPARC ownership analysis with price movements and financial performance for a complete investment picture. (See Sun Pharma Advanced Research C networth)